Drug data last refreshed 10m ago · AI intelligence enriched 1mo ago
PRE-OP II is a topical antimicrobial sponge containing hexachlorophene, approved in 1978 for surgical site antisepsis and preoperative skin preparation. It is applied directly to surgical sites to reduce bacterial colonization and lower infection risk. The drug works through broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria.
With lifecycle stage at LOE approaching and moderate competitive pressure (30%), the brand team is likely in defensive maintenance mode with smaller headcount and focus on market retention.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PRE-OP II offers experience in managing a legacy surgical product with established clinical value but limited growth potential. Roles are primarily focused on defending market share, maintaining healthcare provider relationships, and navigating competitive and regulatory challenges rather than driving innovation or expansion.
Worked on PRE-OP II at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.